Joslin Diabetes Center Receives ‘Challenge’ CME Grant Funding from Pfizer to Fund Research to Assist in the Advancement of Evidence-Based Care for Diabetes and Related Conditions
BOSTON, May 3, 2011 /PRNewswire-USNewswire/ — Joslin Diabetes Center, an affiliate of Harvard Medical School, is launching a landmark Performance Improvement Continuing Medical Education (PI CME) research initiative to establish accuracy and predictive value of current assessment methodologies for CME in order to inform ongoing efforts to improve diabetes care.
The research, already partially funded with a grant from Pfizer, will measure the impact of educational and non-educational interventions on practice. The leading clinical informatics provider Forward Health Group, Inc. will aggregate and automate a process to collect electronic data to track actual performance in clinical practice in areas specific to diabetes and cardiometabolic risk. These data will be used to set the standard for comparisons of other assessment methodologies, including self-report, competency assessment and chart pull techniques.
According to Julie Brown, Executive Director, Professional Education at Joslin, “with the challenges in our nation’s health system, and specifically with chronic illness, certified continuing medical education (CME) must play a vital role in ensuring practitioners are aware of and competent in the latest evidence-based best practice for care. In order for providers of CME to offer the most effective programs, we need to have a better understanding of the most efficient and effective ways to arrive at the outcomes we are striving for and this research is a crucial significant step towards that goal.”
According to Pfizer’s Chief Medical Officer, Dr. Freda Lewis-Hall, “Pfizer recognizes the value of continuing medical education. We have experienced firsthand how effective medical education can provide valuable information about treatment approaches that may reduce the enormous burden chronic illnesses place on our communities and the nation.”
Pfizer has supported 50% of this grant as a challenge to other commercial supporters to step up and support this important research. The findings from this research will undoubtedly inform and perhaps change the metrics and reporting methods currently acceptable for the assessment of performance in practice linked to CME and PI CME for health care professionals.
About Joslin Diabetes Center
Joslin Diabetes Center is the world’s preeminent diabetes research and clinical care organization. Joslin is dedicated to ensuring that people with diabetes live long, healthy lives and offers real hope and progress toward diabetes prevention and a cure. Founded in 1898 by Elliott P. Joslin, M.D., Joslin is an independent, nonprofit institution affiliated with Harvard Medical School. For more information on Joslin, visit www.joslin.org. For more information about the Joslin Professional Education Continuum, visit www.jpec.joslin.org.
About Forward Health Group
Forward Health Group is a leading-edge clinical informatics company, transforming fragmented clinical and administrative healthcare data stored in disparate systems into actionable information that can be used to drive population health improvement. For more information, visit www.forwardhealthgroup.com.
SOURCE Joslin Diabetes Center